Grant Pickering - Mar 2, 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role: Chief Executive Officer, Director
Signature: /s/ Ron Metzger, Attorney-in-Fact
Stock symbol: PCVX
Transactions as of: Mar 2, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/4/2022, 07:50 PM
Previous filing: Jan 31, 2022
Next filing: Mar 21, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCVX	Common Stock	Award	$0	+71.9K	+11.37%	$0.00	704K	Mar 2, 2022	Direct	F1
holding	PCVX	Common Stock						356K	Mar 2, 2022	By Children's Trusts

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCVX	Stock Option (right to buy)	Award	$0	+431K		$0.00	431K	Mar 2, 2022	Common Stock	431K	$24.79	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 2, 2022 and 12.5% of the shares every six months thereafter.
F2	1/48 of shares subject to the option vest on April 2, 2022, and 1/48 of the shares vest monthly thereafter.